Assessing MBX Biosciences (MBX) Valuation After A 261% One Year Total Shareholder Return [Yahoo! Finance]
MBX Biosciences, Inc. (MBX)
Company Research
Source: Yahoo! Finance
MBX Biosciences (MBX) has drawn attention after posting a total return of about 261% over the past year, with recent gains in the month and past 3 months prompting closer scrutiny of its clinical pipeline and cash burn. See our latest analysis for MBX Biosciences. The recent move in MBX Biosciences' share price to $42.39, alongside a 31.65% 1 month share price return and 149.35% 3 month share price return, fits into a year where the 1 year total shareholder return of 261.38% points to strong momentum rather than a short lived spike. Investors are reacting to clinical progress and reassessing the risk around its development pipeline and cash use. If MBX Biosciences' run has you looking beyond a single name, this could be a good moment to scan other specialist healthcare stocks that might fit your watchlist. With MBX Biosciences now at $42.39 after a very strong 1 year total return, plus a price target implying further upside, the key question is whether the recent surge leaves
Show less
Read more
Impact Snapshot
Event Time:
MBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBX alerts
High impacting MBX Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
MBX
News
- MBX Biosciences (NASDAQ:MBX) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.MarketBeat
- MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee ChairGlobeNewswire
- MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
MBX
Earnings
- 11/6/25 - Beat
MBX
Sec Filings
- 1/22/26 - Form 4
- 1/22/26 - Form 3
- 1/22/26 - Form 8-K
- MBX's page on the SEC website